After adjusting for tumor size and tumor grade, the risk of breast cancer death was positively associated with the Recurrence Score (continuous variable in 50-unit increments) among ER-negative patients (relative risk 6.2, 95% CI 1.2–31.8). The gene discussed is ESR1; the disease is breast cancer.